HR Execs on the Move

INFOHEALTH Management

www.infohealth.net

 
INFOHEALTH Management Corp. is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

HealthEd

HealthEd is a specialized agency that uses education to help people develop the knowledge, skills, motivation, and confidence to manage important health decisions and activities and ultimately achieve better health outcomes.

Automotive Innovations Inc

Automotive Innovations Inc is a Bridgewater, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Comprehensive Medical Billing Solutions

Comprehensive Medical Billing Solutions is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community Healthcare Network of New York

Community Healthcare Network of New York is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Community Healthcare Network of New York is based in New York, NY. You can find more information on Community Healthcare Network of New York at www.chnnyc.org

Synthetic Biologics

Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.